Allison Goldfine
Company: Novartis
Job title: Director, Translational Medicine Cardiometabolic Disease
Seminars:
Chair’s Closing Remarks 5:00 pm
day: Day One
Standardizing or Evolving Beyond Biopsy? Clarifying the Next Step to Monitor Disease Progression & Establish Therapeutic Efficacy 2:45 pm
day: Day One